Skip to content

Intraoperative Methadone for the Prevention of Postoperative Pain

Intraoperative Methadone for the Prevention of Postoperative Pain: a Randomized, Double-blind Clinical Study in Orthopedic Surgery

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05831345
Enrollment
80
Registered
2023-04-26
Start date
2023-02-28
Completion date
2025-12-31
Last updated
2025-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Orthopedic Surgery

Brief summary

The pain felt after orthopedic surgery in the absence of adequate locoregional anesthesia is often insufficiently controlled, especially during the first 24 hours postoperatively. Methadone, due to its long half-life, may provide better pain control after orthopedic surgery when associated locoregional anesthesia cannot be performed. It may be impossible to perform loco-regional anesthesia in various contexts: patient refusal, pre-existing neurological impairment, infection at the injection site, coagulopathies, inability to cooperate, total language barrier, allergy to anesthetics, unavailability of equipment (ultrasound, etc.) or equipped room, lack of experience of nursing staff in performing the block and in the postoperative management of the patient. Intraoperative administration of methadone in these settings may be superior to sufentanil for pain control during the 24 hours post orthopedic surgery, and the pain control provided by methadone does not appear to imply a higher likelihood of adverse events related to opioids.

Interventions

Classic induction of anesthesia (opioid, hypnotic and curare) but the team is blinded to the opioid used (sufentanil or methadone), which is prepared in identical syringes by the pharmacy

Classic induction of anesthesia (opioid, hypnotic and curare) but the team is blinded to the opioid used (sufentanil or methadone), which is prepared in identical syringes by the pharmacy

Sponsors

Brugmann University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Age between 18 and 80 years old * ASA 1-3 status * Elective partial or total hip and knee arthroplasty

Exclusion criteria

* Patient refusal * Preoperative renal failure (serum creatinine \> 2 mg/dL or 1.5-fold * Increase in basal plasma creatinine or GFR \< 90 ml/min/1.73m2) * Significant hepatic dysfunction (PT \<50% or increase in 3 times basal transaminases) * Known heart failure * Preoperative hemodynamic instability (preoperative use of inotropes or vasopressors) * Known methadone or sufentanil allergy * Preoperative opioid use or history of opioid abuse * Pregnancy and breastfeeding.

Design outcomes

Primary

MeasureTime frameDescription
Total morphine consumption72 hoursTotal morphine consumption
Standard visual analogue scale (VAS)24 hoursPain is assessed using a standard visual analogue scale (VAS) in 11 points (from 0 (no pain) to 10 (worst pain))

Secondary

MeasureTime frameDescription
Patient satisfaction72 hoursPatient satisfaction is assessed by means of a questionnaire at the end of hospital stay

Countries

Belgium

Contacts

Primary ContactRiccardo Mora, MD
riccardo.mora@chu-brugmann.be00393292199132

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026